Eliquis Offered to Cash-Paying Patients at More Than 40% Discount to Current List Price, Sotyktu at More Than 80% Discount to Current List Price PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb ...
Cellares to provide proof-of-concept manufacturing for a key BMS CAR-T cell therapy Cellares' proprietary Cell Shuttle is a cost-efficient, reliable, fully automated, and highly scalable manufacturing ...
Eliquis 360 Support Program Now Offers Eliquis to Cash-Paying Patients at More than 40% Discount to Current List Price PRINCETON, N.J.--(BUSINESS WIRE)-- The Bristol Myers Squibb-Pfizer (BMS NYSE: BMY ...
The story of Bristol Myers Squibb dates back to the 1800s, so the pharma giant has seen how science has evolved over the past few centuries. Yet in its latest marketing effort, the drugmaker is ...
Bristol-Myers Squibb Co (NYSE:BMY) filed a lawsuit on Tuesday against the U.S. Health Resources and Services Administration (HRSA) and the U.S. Department of Health and Human Services (HHS), alleging ...
-- Bristol Myers Squibb exercises an exclusive license option for ArsenalBio’s AB-4000 series programs-- -- ArsenalBio is eligible for additional milestone payments and royalties as the programs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results